Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Sales (2021 - 2024)

Solid Biosciences (SLDB) has disclosed Return on Sales for 4 consecutive years, with 507.28% as the latest value for Q4 2024.

  • Quarterly Return on Sales fell 29528.0% to 507.28% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 354.7% through Dec 2024, down 44786.0% year-over-year, with the annual reading at 833.0% for FY2025, 118770.0% down from the prior year.
  • Return on Sales hit 507.28% in Q4 2024 for Solid Biosciences, up from 401.66% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 905.26% in Q3 2023 to a low of 13.15% in Q1 2022.
  • Historically, Return on Sales has averaged 265.37% across 4 years, with a median of 123.39% in 2022.
  • Biggest five-year swings in Return on Sales: soared 91631bps in 2023 and later crashed -61052bps in 2024.
  • Year by year, Return on Sales stood at 6.91% in 2021, then plummeted by -86bps to 12.83% in 2022, then skyrocketed by 6356bps to 802.56% in 2023, then crashed by -37bps to 507.28% in 2024.
  • Business Quant data shows Return on Sales for SLDB at 507.28% in Q4 2024, 401.66% in Q3 2024, and 287.62% in Q2 2024.